1. Home
  2. Labeler Index
  3. Aphena Pharma Solutions - Tennessee, Llc
  4. 71610-947
  5. Product Images: Pregabalin

Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Label - 71610 0947 30
  2. Aphena - Aphena
  3. Chemical Structure - pregabalin 01
  4. Figure 1 - pregabalin 02
  5. Figure 2 - pregabalin 03
  6. Figure 3 - pregabalin 04
  7. Figure 4 - pregabalin 05
  8. Figure 5 - pregabalin 06
  9. Figure 6 - pregabalin 07
  10. Figure 7 - pregabalin 08
  11. Figure 9 - pregabalin 09
  12. Figure 10 - pregabalin 10
  13. Figure 11 - pregabalin 11
  14. Figure 12 - pregabalin 12

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 71610-947 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 71610 0947 30

Label - 71610 0947 30

Aphena - Aphena

Aphena - Aphena

Chemical Structure - pregabalin 01

Chemical Structure - pregabalin 01

Figure 1 - pregabalin 02

Figure 1 - pregabalin 02

Figure 2 - pregabalin 03

Figure 2 - pregabalin 03

Figure 3 - pregabalin 04

Figure 3 - pregabalin 04

This evaluation compares the percentage of patients showing improvement in pain levels with different doses of Pregabalin (300mg, 150mg, and 75mg two times a day) and a placebo. The percentages of improvement in pain levels are displayed visually in a graph.*

Figure 4 - pregabalin 05

Figure 4 - pregabalin 05

This is a report showing the percentage of patients whose pain improved with different treatments. Pregabalin at 200 mg three times a day led to a significant improvement, followed by pregabalin at 100 mg three times a day, and finally placebo. The chart includes data points indicating the percent improvement in pain from baseline for each treatment group.*

Figure 5 - pregabalin 06

Figure 5 - pregabalin 06

This text provides information on the percent of patients improved with different treatments: Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, and Placebo, measured in terms of percent improvement in pain from baseline. It presents data points ranging from 20 to 100 percent improvement.*

Figure 6 - pregabalin 07

Figure 6 - pregabalin 07

Figure 7 - pregabalin 08

Figure 7 - pregabalin 08

Seizure Reduction data for three different studies (E1, E2, E3) at varying dosages of Pacabo. The table shows the median percentage change from baseline in seizure frequency. The studies were conducted at different dosing frequencies (BID - twice a day, TID - three times a day).*

Figure 9 - pregabalin 09

Figure 9 - pregabalin 09

This text provides information on the percentage of patients improved with different doses of Pregabalin and a Placebo. The doses mentioned are 600 mg, 450 mg, and 300 mg per day. The data includes measurements taken at different intervals to indicate the improvement in pain from the baseline.*

Figure 10 - pregabalin 10

Figure 10 - pregabalin 10

Figure 11 - pregabalin 11

Figure 11 - pregabalin 11

This text provides information on the percentage of subjects that improved from baseline to Week 12 in a particular study. The data seems to be represented in a numerical format, showing different values for improvement percentages at different time points. The text seems to be focuses on analyzing the improvement of subjects over a certain period of time.*

Figure 12 - pregabalin 12

Figure 12 - pregabalin 12

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.